| C20orf181 |
|
chromosome 20 open reading frame 181
|
|
|
0.479 |
0.885 |
| RNU4ATAC |
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
|
0.556 |
0.808 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| CERNA3 |
|
competing endogenous lncRNA 3 for miR-645
|
|
|
0.531 |
0.808 |
| H3P28 |
|
H3 histone pseudogene 28
|
|
|
0.553 |
0.692 |
| XRCC6P5 |
|
X-ray repair cross complementing 6 pseudogene 5
|
|
|
0.579 |
0.769 |
| TRNE |
|
tRNA
|
|
|
0.647 |
0.692 |
| MIR148B |
|
microRNA 148b
|
|
|
0.592 |
0.692 |
| FRAXA |
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
|
0.641 |
0.462 |
| FMR1-IT1 |
|
FMR1 intronic transcript 1
|
|
|
0.716 |
0.385 |
| MORF4 |
|
mortality factor 4 (pseudogene)
|
|
|
0.705 |
0.423 |
| AQP4-AS1 |
|
AQP4 antisense RNA 1
|
|
|
0.751 |
0.577 |
| ST20-MTHFS |
|
ST20-MTHFS readthrough
|
|
7.6E-03 |
0.805 |
0.115 |
| PCAT2 |
|
prostate cancer associated transcript 2
|
|
|
0.751 |
0.462 |
| MIR3191 |
|
microRNA 3191
|
|
|
0.931 |
0.077 |
| SCA18 |
|
spinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy)
|
|
|
|
|
| SCA37 |
|
spinocerebellar ataxia 37
|
|
|
0.931 |
0.115 |
| CLA3 |
|
cerebellar ataxia 3 (cerebellar parenchyma disorder 1)
|
|
|
1.000 |
0.038 |
| SCA26 |
|
spinocerebellar ataxia 26
|
|
|
|
|
| IGLON5 |
A6NGN9
|
IgLON family member 5
|
|
0.40 |
0.839 |
0.308 |
| PRNP |
F7VJQ1 P04156
|
prion protein
|
|
6.3E-04 |
0.445 |
0.923 |
| CACNB4 |
O00305
|
calcium voltage-gated channel auxiliary subunit beta 4
|
Ion channel
|
3.1E-02 |
0.653 |
0.231 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| DNM1L |
O00429
|
dynamin 1 like
|
Enzyme modulator
|
5.7E-04 |
0.475 |
0.808 |
| IFRD1 |
O00458
|
interferon related developmental regulator 1
|
|
1.2E-03 |
0.666 |
0.462 |